Literature DB >> 2751333

Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours.

E A Livesey1, C G Brook.   

Abstract

We investigated thyroid function in 119 survivors of treatment for brain tumours not involving the hypothalamo-pituitary region. Cranial irradiation did not effect thyroid function but 11 of 47 children (23%) who had spinal irradiation had raised concentrations of thyroid stimulating hormone. Chemotherapy further increased the incidence of thyroid dysfunction: two of four patients who had cranial irradiation and chemotherapy and 20 of 29 patients (69%) who had spinal irradiation and chemotherapy had increased thyroid stimulating hormone concentrations. Only six patients with raised thyroid stimulating hormone concentrations had low serum thyroxine concentrations. Four children had secondary hypothyroidism. Thyroid function should be monitored in children who have received chemotherapy or radiotherapy. A rise in thyroid stimulating hormone concentrations is the most sensitive indicator of thyroid dysfunction. Children with raised thyroid stimulating hormone concentrations should be treated with thyroxine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2751333      PMCID: PMC1791957          DOI: 10.1136/adc.64.4.593

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  16 in total

Review 1.  EFFECTS INCLUDING CARCINOGENESIS OF I-131 AND X-RAYS ON THE THYROID OF EXPERIMENTAL ANIMALS: A REVIEW.

Authors:  I DONIACH
Journal:  Health Phys       Date:  1963-12       Impact factor: 1.316

2.  Endocrine sequelae of antineoplastic therapy in childhood head and neck malignancies.

Authors:  D R Bajorunas; F Ghavimi; B Jereb; M Sonenberg
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

3.  The effect of varying doses of cerebral irradiation on growth hormone production in childhood.

Authors:  S M Shalet; C G Beardwell; D Pearson; P H Jones
Journal:  Clin Endocrinol (Oxf)       Date:  1976-05       Impact factor: 3.478

4.  Growth and endocrine function after treatment for medulloblastoma.

Authors:  I H Brown; T J Lee; O B Eden; J A Bullimore; D C Savage
Journal:  Arch Dis Child       Date:  1983-09       Impact factor: 3.791

5.  Thyroid abnormalities associated with treatment of malignant lymphoma.

Authors:  K Tamura; K Shimaoka; M Friedman
Journal:  Cancer       Date:  1981-06-01       Impact factor: 6.860

6.  Endocrine morbidity in adults treated with cerebral irradiation for brain tumours during childhood.

Authors:  S M Shalet; C G Beardwell; I A MacFarlane; P H Jones; D Pearson
Journal:  Acta Endocrinol (Copenh)       Date:  1977-04

7.  Primary gonadal damage following treatment of brain tumors in childhood.

Authors:  S R Ahmed; S M Shalet; R H Campbell; D P Deakin
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

8.  Cyclical combination chemotherapy and thyroid function in patients with advanced Hodgkin's disease.

Authors:  S B Sutcliffe; R Chapman; P F Wrigley
Journal:  Med Pediatr Oncol       Date:  1981

9.  Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism.

Authors:  E C Ridgway; D S Cooper; H Walker; D Rodbard; F Maloof
Journal:  J Clin Endocrinol Metab       Date:  1981-12       Impact factor: 5.958

10.  Long-term effects of treatment on endocrine function in children with brain tumors.

Authors:  P K Duffner; M E Cohen; S W Anderson; M L Voorhess; M H MacGillivray; A Panahon; M L Brecher
Journal:  Ann Neurol       Date:  1983-11       Impact factor: 10.422

View more
  14 in total

Review 1.  Endocrine sequelae of cancer therapy in childhood.

Authors:  F B Diamond; B B Bercu
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

2.  Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols.

Authors:  A Corrias; S Einaudi; U Ricardi; A Sandri; L Besenzon; F Altare; L Artesani; L Genitori; M Andreo; C De Sanctis
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

3.  Thyroid function and thyroid autoimmunity in childhood acute lymphoblastic leukemia off-therapy patients treated only with chemotherapy.

Authors:  M Delvecchio; V Cecinati; L P Brescia; M F Faienza; D De Mattia; L Cavallo; N Santoro
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

4.  Target Gland Dysfunction Following External Cranial Radiation for Extrasellar Tumours.

Authors:  M K Garg
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Endocrine consequences of treatment of malignant disease.

Authors:  S M Shalet
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

6.  The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation.

Authors:  Christine Lauro; Margaret E Macy; Philip Zeitler; Jennifer Backus; Pamela Mettler; Nicholas Foreman; Arthur K Liu
Journal:  J Pediatr Endocrinol Metab       Date:  2014-03       Impact factor: 1.634

7.  Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study.

Authors:  Wassim Chemaitilly; Zhenghong Li; Sujuan Huang; Kirsten K Ness; Karen L Clark; Daniel M Green; Nicole Barnes; Gregory T Armstrong; Matthew J Krasin; Deo Kumar Srivastava; Ching-Hon Pui; Thomas E Merchant; Larry E Kun; Amar Gajjar; Melissa M Hudson; Leslie L Robison; Charles A Sklar
Journal:  J Clin Oncol       Date:  2015-01-05       Impact factor: 44.544

Review 8.  Late effects of antineoplastic therapy in childhood on growth and endocrine function.

Authors:  W H Wallace; C J Kelnar
Journal:  Drug Saf       Date:  1996-11       Impact factor: 5.606

9.  Endocrine functions in long-term survivors of low-grade supratentorial glioma treated with radiation therapy.

Authors:  M J Taphoorn; J J Heimans; E A van der Veen; A B Karim
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  NORMAL TISSUE REACTIONS TO CHRONIC RADIATION EXPOSURE IN MAN.

Authors:  A V Akleyev
Journal:  Radiat Prot Dosimetry       Date:  2016-07-29       Impact factor: 0.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.